Dihydroartemisinin/Piperaquine for the treatment of uncomplicated P. falciparum malaria

descriptionPublicationkeyboard_double_arrow_right Conference object 01 Jan 2010Embargo end date: 02 Jun 2010 English Publisher:German Medical Science GMS Publishing House; Düsseldorf

Authors: Corsi, M;

doi: 10.3205/10kit048

Dihydroartemisinin/Piperaquine for the treatment of uncomplicated P. falciparum malaria

- Summary
- Subjects
- Metrics

Abstract

Dihydroartemisinin/Piperaquine is a fixed-dose Artemisinin-based Combination Therapy (ACT) which contains dihydroartemisinin (DHA), a derivative of artemisinin, and piperaquine (PQP). It has been developed for the treatment of uncomplicated Plasmodium falciparum malaria. The registration Dossier[for full text, please go to the a.m. URL]

10. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)

Keywords

ddc: 610, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average